Supports healthy circulation Preliminary research has explored BPC-157's potential to support healthy circulation, which plays an important role in delivering oxygen and nutrients throughout the body
We identified three main findings
PMID: 41884085, PMCID: PMC13012015, DOI: 10.18332/tid/217143.Peer-Reviewed Original ResearchConceptsUnannounced standardized patientsMultiphase optimization strategyEvidence-based practicePrimary healthcareImplementation strategiesStandardized patientsSmoking cessationBest-worst scalingMultiphase Optimization Strategy frameworkProgram Sustainability Assessment ToolMultifaceted implementation strategyEffectiveness-implementation trialImplementation Outcomes FrameworkNormalization Process TheoryPrimary healthcare servicesTobacco cessation interventionsMulti-component interventionPrimary care clinicsPrimary healthcare institutionsProbability proportional to sizeOptimal implementation strategiesTelephone Follow-UpMiddle-income countriesVerbal interventionsProportional to size Academic Achievements & Community Involvement Copy Link Activities activity Journal of the American College of Cardiology 04/01/2024 - PresentJournal ServiceStatistical Editor activity BMC Medicine 07/01/2023 - PresentJournal ServiceEditorial Board Member activity American Statistical Association Connecticut Chapter 07/01/2022 - PresentProfessional OrganizationsTreasurer activity JAMA Cardiology 2021 - PresentJournal ServiceReviewer activity Global Cardiovascular Research Funders Forum 2025 - 2025Peer Review Groups and Grant Study SectionsReview Panel MemberDetailsReviewer for International Research Challenge on Womens Cardiovascular Health
To get it approved, you would need to: Buy the patent (its for sale) Figure out a specific disease indication to apply for BPC-157 approval Hire a research team to run phase 1, 2, 3 trials The financial incentives make it so that BPC-157 will likely never go through the full FDA approval process, which is a shame given how promising this compound is
Apr 2014;112(4):296-301
Promoter analysis and chromatin immunoprecipitation were employed to identify OGT-targeted transcription factor that mediates the expression of the paracrine factor
